IMMUNE RESPONSE RELATED HEPATITIS MODELS
Validated in vivo models to emulate liver injury for your preclinical studies.
T cell and macrophage-dependent hepatic damage can be assessed using a variety of models, including Acute Liver Failure (ALF) induced by Acetaminophen (N-acetyl-p-aminophenol [APAP]) overdose, or con A-induced liver injury. Whichever model your study needs, PharmaLegacy is your go-to. Founded in 2008 by scientific experts and still staffed by scientists with an average of 15 years of experience in pharmacology, Pharmalegacy has been chosen by more than half of the top 20 pharmaceutical companies to run their in vivo preclinical studies. Choosing the right CRO has never been easier.
MODELS / SERVICES
Case Study: Concanavalin A-induced Liver Injury in Mice
ALT Increase in Con A-Induced Liver Injury and Protection by Dex
AST Increase in Con A-Induced Liver Injury and Protection by Dex
TNF-α Increase in Con A-Induced Liver Injury
IL-6 Increase in Con A-Induced Liver Injury
Ensuring superior quality:
- 43,000 square feet of vivarium space
- Electronically managed, traceable research data
- Scientific staff with an average of over 15 years of experience in pharmacology
- AAALAC and CNAS guidelines-adherent animal studies